OM

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Outset Medical Inc

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
CEO
Employees
313
Headquarters

News

Mayor to Marseille: Don''t sign Greenwood deal
Jul 10, 2024 03:39am


Source:Kwhen Finance
Outset Medical executive sells over $50k in company stock
Jun 14, 2024 20:20pm

https://www.investing.com/news/company-news/outset-medical-executive-sells-over-50k-in-company-stock-93CH-3485613


Source:Investing.com
Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Jun 03, 2024 20:05pm

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 45th annual Healthcare conference on Wednesday, June 12, 2024, at 11:20 a.m. Eastern time. A live and archived webcast of the presentation will be available on the Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online